Introduction: Abnormal hemoglobin is a hallmark of sickle cell disease (SCD), a genetic blood abnormality that can cause a number of clinical consequences, such as vaso-occlusive crises and an elevated risk of infection. One potential biomarker for evaluating disease activity and...
Open access
Research Article10.9734/ijr2h/2024/v7i2157
Introduction: Sickle cell disease is a genetic disorder predominant among people of African origin. Nigeria has the highest burden of the disease in the world. Demographic factors have been shown to influence the clinical manifestation of the disease. Understanding sex and age-re...
Open access
Research Article10.9734/ijr2h/2024/v7i2156
Introduction: Nigeria has the greatest global burden of sickle cell disease (SCD), a hereditary illness that is common among persons of African origin. Understanding the etiology of the disease depends on biomarkers like fibrinogen degradation products (FDP) and C-reactive protei...
Open access
Research Article10.9734/ijr2h/2024/v7i2155
Background: While coagulation and fibrinolytic activity are rarely evaluated, infectious diseases are the main focus of blood donor screening. Subclinical anomalies in hemostatic activities could affect transfusion results and present unnoticed dangers to donor health. Aim and Ob...
Open access
Research Article10.9734/ijr2h/2025/v8i2196